SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech fireworks

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JMarcus who wrote (1364)12/19/2003 6:02:45 PM
From: JMarcus  Read Replies (1) of 7424
 
ISV announced a deal just before the close of trading. The deal wasn't a partnership with Bausch & Lomb for ISV-401 but a sale of ISV-403 to Bausch & Lomb. ISV gets cash, a royalty, and cancellation of the Series A-1 Preferred Stock previously issued to B&L. This has to be better than an immediate bankruptcy for ISV. The press release was published at 3:49 PM (strange timing), sending the stock up 26%.

Marc
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext